Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Pozycja w akcjach #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Cena akcji
$267.84
Kapitalizacja rynkowa
$645.47B
Zmiana (1 dzień)
-0.63%
Zmiana (1 rok)
51.68%
Kraj
US
Handel Johnson & Johnson (JNJ)

Kategoria

Zyski dla Johnson & Johnson (JNJ)
Zyski w Jun 2026 TTM: $25.20B
Według najnowszych raportów finansowych Johnson & Johnson, obecny zysk firmy wynosi $25.20B. W roku 2024 firma osiągnęła zysk w wysokości $16.69B, wzrost w porównaniu do zysku z roku 2023, który wynosił $15.06B. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Johnson & Johnson od 2000 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $25.20B -22.67%
2025 $32.58B 95.25%
2024 $16.69B 10.79%
2023 $15.06B -21.46%
2022 $19.18B 16.25%
2021 $16.50B -4.80%
2019 $17.33B -3.73%
2018 $18.00B 1.84%
2017 $17.67B -10.76%
2016 $19.80B 3.16%
2015 $19.20B -6.65%
2014 $20.56B 32.91%
2013 $15.47B 12.31%
2012 $13.78B 11.44%
2011 $12.36B -27.06%
2010 $16.95B 7.57%
2009 $15.76B -6.93%
2008 $16.93B 27.45%
2007 $13.28B -8.94%
2006 $14.59B 11.22%
2005 $13.12B 6.37%
2004 $12.33B 19.63%
2003 $10.31B 10.95%
2002 $9.29B 17.64%
2001 $7.90B 15.00%
2000 $6.87B 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$33.60B 33.34%
US
$8.70B -65.47%
US
$21.39B -15.11%
CH
$5.95B -76.39%
US
$16.38B -35.00%
CH